Back to Journals
Stem Cells and Cloning: Advances and Applications
Directeur de Recherche INSERM, Faculte de Medecine, Inserm, France
Editor-in-Chief: Dr Bernard Binetruy
Dr Bernard Binetruy
Position: Research Director at Inserm (french governemental agency for medical research).
Track record:1980: Master in biochemistry and physiology at the University of Nice.1981-1988: PhD student (1981-1982), then INSERM researcher (1983-1988) at the Centre de Biochimie, Nice (scientifc director Dr F. Cuzin). My research was focused on the oncogenic properties of the Bovine Papilloma Virus type1 (BPV1) in rat embryo fibroblasts.
Publications: Nature, EMBO J., Virology, PNAS and Oncogene.
October 1982: Thèse de 3ème cycle and Nov. 1988: Thèse de doctorat d'état in microbiology, University of Nice.
December 1988-June 1991: post-doc fellow in the laboratory of Dr M. Karin, department of pharmacology, School of medicine, UCSD, La Jolla, USA. Fellowship of the Fogarty International Center. During my stay in San Diego I showed that the Ras oncogene augments cJun activity and stimulates phosphorylation of its activation domain and that oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of cJun on serines 63 and 73. This work led to the identification and the characterisation, two years later, by the laboratory of M. Karin of the JNK signal transduction pathway.
Publications: two in Nature (one « full paper ») and two in Mol. Cell. Biol.
June 1991-September 1999: back in France, I started my own lab in Paris area in the Cancer Research Institute, CNRS, Villejuif. We developed a differential screening of a cDNA library to identify and then characterize c-Jun target genes.
Publications: EMBO J., Mol. Cell. Biol., Oncogene and Cell Growth & Diff.
October 1995: Research Director at Inserm.
September 1999-August 2005: I moved to Nice, Inserm U568 laboratory, Faculté de Médecine, Nice. In this new laboratory, I started a new research program focused on the analysis of the molecular mechanisms involved in the differentiation of mouse ES cells.
Publications: Oncogene, Biochem. J., CMLS, Diabetes and Stem Cells.
Since September 2005: I moved to Marseille, Inserm UMR626 laboratory, Faculté de Médecine Timone, Marseille. In this lab, I continue my research on the differentiation of ES cells.
From January 2008: I am the Director of the Institut de Physiopathologie Humaine de Marseille, IFR 125.
Prof. Dr. Blumenfeld
Zeev Blumenfeld, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel
Pankaj Chaturvedi, Dr. Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Michael Griswold, Professor, School of Molecular Biosciences, College of Sciences, Washington State University, WA, USA
Dan Liebermann, Professor of The Fels Institute for Cancer Research and Molecular biology; Professor of Medical Genetics & Molecular Biochemistry, Temple Univ. School of Medicine, Philadelphia, PA, USA
Joseph Locker, Professor, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Andres Matoso, Department of Pathology, Johns Hopkins University, Baltimore, MD, USA
Colin P McGuckin, Professor and President, Cell Therapy Research Institute, Lyon, France
Louis M Pelus, Professor, Department of Microbiology and Immunology, Indiana University School of Medicine, IN, USA
John J. Rossi, Lidow Family Research Chair, Professor, Department of Molecular Biology, Dean, Graduate School of Biological Sciences, Beckman Research Insitute of the City of Hope, Duarte, CA, USA
Dario Siniscalco, ChemD, PhD, Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy Dario Siniscalco, Department of Experimental Medicine, School of Medicine and Surgery, Second University of Naples, Italy
Kiminobu Sugaya, Professor of Medicine and Head of Neuroscience, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, FL, USA
Marco Tatullo, Scientific Director of Tecnologica Research Institute, Biomedical Section, Stem Cells Unit, Crotone, Italy
Cory Xian, UniSA Clinical & Health Sciences, University of South Australia, Australia
Martin L. Yarmush, MD, PhD, Paul and Mary Monroe Chair of Science and Engineering and Distinguished Professor of Biomedical Engineering, Rutgers University, Piscataway, NJ, USA
John A. Zaia, M.D., Director, Center for Gene Therapy, Aaron D. and Edith Miller Chair for Gene Therapy; Hematologic Malignancies and Stem Cell Transplantation Institute Department of Hematology, City of Hope, Duarte, CA, USA